Royalty Pharma
Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry.
New York, United States · 9+ investments · 7 portfolio companies
- Headquarters
- New York, United States
- Founded
- 1996
- Website
- royaltypharma.com
- AUM
- $18.0B
- Portfolio Companies
- 7
- Total Investments
- 9
- Last Investment
- Dec 2025
- Geographic Focus
- United States, Global
Investment Thesis
Royalty Pharma is a Venture Capital firm based in New York, United States. It has made 9 investments, including BioCryst Pharmaceuticals, Syndax Pharmaceuticals and Denali Therapeutics. Focus areas include Biotech and Healthcare.
Portfolio7
Co-investors24
Sign up to view co-investors
24 co-investors across 27 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×18 · Other ×2 · Corporate VC ×2 · 12 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/royalty-pharma"><img src="https://indexed.vc/api/badge/investor/royalty-pharma" alt="Royalty Pharma on Indexed.vc" width="260" height="76" /></a>